Results 91 to 100 of about 1,439 (152)

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

Journal of Global Antimicrobial Resistance
: Objectives: We report the use of IV dalbavancin in Canadian patients using data captured by the national CLEAR registry. Methods: The CLEAR registry uses the web-based data management program, REDCap™ (online survey https://rcsurvey.radyfhs.umanitoba ...
George Zhanel, Michael Silverman, Janhavi Malhotra, Melanie Baxter, Reza Rahimi, Neal Irfan, Gabriel Girouard, Rita Dhami, Melissa Kucey, Vida Stankus, Kristin Schmidt, Sébastien Poulin, William Connors, Carlo Tascini, Andrew Walkty, James Karlowsky   +15 more
doaj   +1 more source

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections. [PDF]

Open Forum Infect Dis
Howard-Anderson J, Hamasaki T, Ge L, Collyar D, Cosgrove SE, Doernberg SB, Geres H, Gopinath R, Holland TL, King HA, Nambiar S, Rubin D, Chambers HF, Fowler VG, Evans SR, Boucher HW.   +15 more
europepmc   +1 more source

Stewardship Challenges, PK/PD Evidence, and Prescribing Appropriateness for Recently Approved Antibiotics in Pediatric Practice. [PDF]

Antibiotics (Basel)
Romandini A, Resnati C, Crucitta S, Agliardi S, D'Amico F, Pattarino GAC, Altieri E, Danesi R, De Giacomo C.   +8 more
europepmc   +1 more source

Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis. [PDF]

J Antimicrob Chemother
Rando E, Magrini E, Sangiorgi F, Salvati F, Catania F, Chiuchiarelli M, Matteini E, Fantoni M, Torti C, López-Cortés LE, Rodríguez-Baño J, Murri R.   +11 more
europepmc   +1 more source

Trends in diagnosis of amyloid kidney disease in people who inject drugs (PWID). [PDF]

Prev Med Rep
Narayanan S, Khadke S, Purcell M, Ghoprial A.   +3 more
europepmc   +1 more source

Antibiotic development and a path to access in India. [PDF]

Nat Commun
Manesh A, Walia K, Saiyed T, Veeraraghavan B, Paterson DL.   +4 more
europepmc   +1 more source

Leukocytoclastic Vasculitis Induced by Dalbavancin: A Case Report. [PDF]

Am J Case Rep
Scaglione V, Cola M, Sasset L, Fortarezza F, Casarin C, Trevenzoli M, Dei Tos AP, Cattelan A.   +7 more
europepmc   +1 more source

Budget Impact and Financial Analysis of Outpatient Dalbavancin in an Urban, Non-Teaching, Community Hospital. [PDF]

Clin Drug Investig
Raja K, Chen B, Chandra O, Patel M, Philips M.   +4 more
europepmc   +1 more source

Omadacycline Pharmacokinetics: Characteristics, Contributing Factors, and Clinical Significance. [PDF]

Drugs R D
Sun H, Hou X, Zhu Q, Liu J, Zhai Q, Shi K.   +5 more
europepmc   +1 more source

Outpatient Parenteral Antimicrobial Therapy in a Setting with High Prevalence of Multidrug Resistance: Challenges, Opportunities, and Stewardship Considerations. [PDF]

Antibiotics (Basel)
Ciusa G, Pipitone G, Catania B, Coniglione G, Goad M, Imburgia C, Scordo P, Albanese A, Cascio A, Iaria C.   +9 more
europepmc   +1 more source